Lyra Therapeutics (LYRA) Accounts Payables (2021 - 2025)
Historic Accounts Payables for Lyra Therapeutics (LYRA) over the last 5 years, with Q3 2025 value amounting to $627000.0.
- Lyra Therapeutics' Accounts Payables fell 7264.4% to $627000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $627000.0, marking a year-over-year decrease of 7264.4%. This contributed to the annual value of $1.2 million for FY2024, which is 6234.43% down from last year.
- According to the latest figures from Q3 2025, Lyra Therapeutics' Accounts Payables is $627000.0, which was down 7264.4% from $680000.0 recorded in Q2 2025.
- Over the past 5 years, Lyra Therapeutics' Accounts Payables peaked at $5.1 million during Q3 2023, and registered a low of $627000.0 during Q3 2025.
- In the last 5 years, Lyra Therapeutics' Accounts Payables had a median value of $2.6 million in 2022 and averaged $2.5 million.
- Per our database at Business Quant, Lyra Therapeutics' Accounts Payables soared by 15077.84% in 2023 and then tumbled by 8632.07% in 2025.
- Lyra Therapeutics' Accounts Payables (Quarter) stood at $3.1 million in 2021, then dropped by 16.29% to $2.6 million in 2022, then rose by 19.69% to $3.1 million in 2023, then tumbled by 62.34% to $1.2 million in 2024, then tumbled by 46.82% to $627000.0 in 2025.
- Its Accounts Payables stands at $627000.0 for Q3 2025, versus $680000.0 for Q2 2025 and $725000.0 for Q1 2025.